543520 Stock Overview
Global Longlife Hospital and Research Limited operates multispecialty hospital in India.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Global Longlife Hospital and Research Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹43.29 |
| 52 Week High | ₹61.70 |
| 52 Week Low | ₹36.25 |
| Beta | 0 |
| 1 Month Change | 1.86% |
| 3 Month Change | -21.99% |
| 1 Year Change | -4.86% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -68.02% |
Recent News & Updates
Recent updates
Shareholder Returns
| 543520 | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | 0.7% | -4.1% | -2.5% |
| 1Y | -4.9% | 61.1% | 44.5% |
Return vs Industry: 543520 underperformed the Indian Healthcare industry which returned 65% over the past year.
Return vs Market: 543520 underperformed the Indian Market which returned 45.3% over the past year.
Price Volatility
| 543520 volatility | |
|---|---|
| 543520 Average Weekly Movement | 9.3% |
| Healthcare Industry Average Movement | 6.3% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.3% |
Stable Share Price: 543520's share price has been volatile over the past 3 months.
Volatility Over Time: 543520's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 103 | Dhruv Jani | globalhospital.co.in |
Global Longlife Hospital and Research Limited operates multispecialty hospital in India. It offers medical services, such as oncology, ophthalmology, allergy and immunology, pain management, pulmonology, anaesthesiology, cardiology, dermatology, critical care, diabetes and endocrinology, GI medicine, gynecology, infectious disease, nephrology, and neurology; and surgical services, including CVTS, joint replacement orthopaedics, spine surgery, general surgery, onco surgery, GI surgery, neurosurgery, ENT, plastic surgery, trauma centre, urology, laparoscopic surgery, gynaecology, dental surgery, and vascular surgery. The company also provides radiology services consisting of mammography, CT scan, X-ray, ultrasound, endoscopy, and sonography; pathology services, including microbiology, biochemistry, clinical pathology, cyto pathology, haematology, and serology; and other services comprising dialysis, pharmacy, ambulance, dietary, and physiotherapy services.
Global Longlife Hospital and Research Limited Fundamentals Summary
| 543520 fundamental statistics | |
|---|---|
| Market cap | ₹454.55m |
| Earnings (TTM) | ₹20.99m |
| Revenue (TTM) | ₹240.36m |
21.7x
P/E Ratio1.9x
P/S RatioIs 543520 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 543520 income statement (TTM) | |
|---|---|
| Revenue | ₹240.36m |
| Cost of Revenue | ₹172.52m |
| Gross Profit | ₹67.84m |
| Other Expenses | ₹46.85m |
| Earnings | ₹20.99m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.00 |
| Gross Margin | 28.22% |
| Net Profit Margin | 8.73% |
| Debt/Equity Ratio | 17.3% |
How did 543520 perform over the long term?
See historical performance and comparison